*Studies that leverage big data, novel data sources and artificial intelligence/machine learning options that contribute to the continued evaluation of the safety and efficacy of COVID-19 FDA-approved products (therapeutics, diagnostics, and vaccines) by demographic data including, but not limited to, ethnicity, race, age, disability, and geography.